3rd Quarter - Report

AMERICAN ASSOCIATION FOR CANCER RESEARCH for AMERICAN ASSOCIATION FOR CANCER RESEARCH

Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

cancer research oncology product review at the FDA

LobbyistCovered position, as disclosed
MARY LEE WATTS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FY 2018 appropriations for National Institutes of Health FY 2018 appropriations for the Food and Drug Administration STAR Act, H.R. 820

LobbyistCovered position, as disclosed
MARY LEE WATTS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 820 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.